Volume 68 Received 26 October 2012 | ||||||||||
| ||||||||||
aNational Institute of Technology-Karnataka, Department of Chemistry, Medicinal Chemistry Laboratory, Surathkal, Mangalore 575 025, India,bGM Institute of Technology, Department of Physics, Davangere 577 006, India,cSiddaganga Institute of Technololgy, Department of Physics, Tumkur 572 103, India,dSree Siddaganga College for Women, Tumkur 572 103, India, and eNelson Mandela Metropolitan University, Summerstrand Campus, Department of Chemistry, University Way, Summerstrand, PO Box 77000, Port Elizabeth, 6031, South Africa
Correspondence e-mail: richard.betz@webmail.co.za
In the title compound, C14H19N3O2, the heterocycle adopts a 1C4 conformation with the N atom being one of the flap atoms. In the crystal, classical N-H
O hydrogen bonds and C-H
O contacts connect the molecules into a three-dimensional network.
For the pharmacological importance of piperidine and its derivatives, see: Chen et al. (2012
); Boja et al. (2011
); Jakubowska et al. (2012
). For puckering analysis of six-membered rings, see: Cremer & Pople (1975
); Boeyens (1978
). For graph-set analysis of hydrogen bonds, see: Etter et al. (1990
); Bernstein et al. (1995
).
|
|
|
Data collection: APEX2 (Bruker, 2010
); cell refinement: SAINT (Bruker, 2010
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 (Farrugia, 2012
) and Mercury (Macrae et al., 2008
); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: BG2489 ).
AMI is thankful to the Department of Atomic Energy, Board for Research in Nuclear Sciences, Government of India, for a Young scientist award. JMR thanks the Principal of GMIT Davavangere for providing research facilities.
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
![[ISI]](../../../../../../logos/isiborder.gif)
Boeyens, J. C. A. (1978). J. Cryst. Mol. Struct. 8, 317-320. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Boja, P., Won, S., Suh, D. H., Chu, J., Park, W. K. & Lim, H. (2011). Bull. Korean Chem. Soc. 32, 1249-1252. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bruker (2008). SADABS. Bruker Inc., Madison, Wisconsin, USA.
Bruker (2010). APEX2 and SAINT. Bruker AXS Inc., Madison, USA.
Chen, X., Zhan, P., Pannecouque, C., Balzarini, J., Clercq, E. D. & Liu, X. (2012). Eur. J. Med. Chem. 51, 60-66.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
![[ISI]](../../../../../../logos/isiborder.gif)
Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256-262.
![[details]](../../../../../../b/graphics/details.gif)
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
Jakubowska, A., Kulig, K., Guzior, N. & Malawska, B. (2012). Acta Pol. Pharm. Drug Res. 69, 449-455. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.
![[details]](../../../../../../j/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)